USD492769S1 - Lens for an inhaler - Google Patents

Lens for an inhaler Download PDF

Info

Publication number
USD492769S1
USD492769S1 US29/171,385 US17138502F USD492769S US D492769 S1 USD492769 S1 US D492769S1 US 17138502 F US17138502 F US 17138502F US D492769 S USD492769 S US D492769S
Authority
US
United States
Prior art keywords
inhaler
lens
view
shown
taken along
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US29/171,385
Inventor
Satoshi Hatanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline KK
Original Assignee
GlaxoSmithKline KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2002-013914 priority Critical
Priority to JP2002013914 priority
Application filed by GlaxoSmithKline KK filed Critical GlaxoSmithKline KK
Assigned to GLAXOSMITHKLINE K.K. reassignment GLAXOSMITHKLINE K.K. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HATANAKA, SATOSHI
Application granted granted Critical
Publication of USD492769S1 publication Critical patent/USD492769S1/en
Anticipated expiration legal-status Critical
Application status is Expired - Lifetime legal-status Critical

Links

Images

Description

FIG. 1 is a top view of a lens for an inhaler showing my new design;

FIG. 2 is a bottom view thereof;

FIG. 3 is a side view thereof;

FIG. 4 is an end view thereof;

FIG. 5 is an end view thereof, opposite that shown in FIG. 4;

FIG. 6 is a perspective view thereof;

FIG. 7 is an enlarged cross-sectional view thereof, taken along 7—7 of FIG. 1;

FIG. 8 is a partial cross-sectional view thereof, taken along 8—8 of FIG. 3; and,

FIG. 9 is a top view thereof, the broken line showing of the inhaler is for illustrative purposes only and forms no part of the claimed design.

Claims (1)

  1. The ornamental design for a lens for an inhaler, as shown and described.
US29/171,385 2002-05-24 2002-11-21 Lens for an inhaler Expired - Lifetime USD492769S1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2002-013914 2002-05-24
JP2002013914 2002-05-24

Publications (1)

Publication Number Publication Date
USD492769S1 true USD492769S1 (en) 2004-07-06

Family

ID=32588015

Family Applications (1)

Application Number Title Priority Date Filing Date
US29/171,385 Expired - Lifetime USD492769S1 (en) 2002-05-24 2002-11-21 Lens for an inhaler

Country Status (1)

Country Link
US (1) USD492769S1 (en)

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8424518B2 (en) 2008-06-13 2013-04-23 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9358352B2 (en) 2008-06-13 2016-06-07 Mannkind Corporation Dry powder drug delivery system and methods
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
USD767114S1 (en) 2015-03-18 2016-09-20 Amneal Pharmaceuticals Company Gmbh Inhalation device
USD769439S1 (en) 2015-03-18 2016-10-18 Amneal Pharmaceuticals Company Gmbh Inhalation device
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
USD795414S1 (en) 2014-06-03 2017-08-22 Glenmark Specialty S.A. Inhaler
USD797920S1 (en) 2013-11-22 2017-09-19 Glenmark Pharmaceuticals Limited Inhaler
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US9801925B2 (en) 1999-06-29 2017-10-31 Mannkind Corporation Potentiation of glucose elimination
USD804015S1 (en) 2013-12-23 2017-11-28 Glenmark Pharmaceuticals Limited Inhaler
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US9943571B2 (en) 2008-08-11 2018-04-17 Mannkind Corporation Use of ultrarapid acting insulin
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin

Cited By (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9801925B2 (en) 1999-06-29 2017-10-31 Mannkind Corporation Potentiation of glucose elimination
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US10130685B2 (en) 2004-08-23 2018-11-20 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9717689B2 (en) 2005-09-14 2017-08-01 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US10143655B2 (en) 2005-09-14 2018-12-04 Mannkind Corporation Method of drug formulation
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9446001B2 (en) 2005-09-14 2016-09-20 Mannkind Corporation Increasing drug affinity for crystalline microparticle surfaces
US10130581B2 (en) 2006-02-22 2018-11-20 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9192675B2 (en) 2008-06-13 2015-11-24 Mankind Corporation Dry powder inhaler and system for drug delivery
US8912193B2 (en) 2008-06-13 2014-12-16 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9358352B2 (en) 2008-06-13 2016-06-07 Mannkind Corporation Dry powder drug delivery system and methods
US9393372B2 (en) 2008-06-13 2016-07-19 Mannkind Corporation Dry powder drug delivery system
US9339615B2 (en) 2008-06-13 2016-05-17 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8636001B2 (en) 2008-06-13 2014-01-28 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9446133B2 (en) 2008-06-13 2016-09-20 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9662461B2 (en) 2008-06-13 2017-05-30 Mannkind Corporation Dry powder drug delivery system and methods
US9511198B2 (en) 2008-06-13 2016-12-06 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8499757B2 (en) 2008-06-13 2013-08-06 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
US10201672B2 (en) 2008-06-13 2019-02-12 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8424518B2 (en) 2008-06-13 2013-04-23 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9943571B2 (en) 2008-08-11 2018-04-17 Mannkind Corporation Use of ultrarapid acting insulin
US9655850B2 (en) 2008-12-29 2017-05-23 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US10172850B2 (en) 2008-12-29 2019-01-08 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
US10130709B2 (en) 2011-06-17 2018-11-20 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US10258664B2 (en) 2011-10-24 2019-04-16 Mannkind Corporation Methods and compositions for treating pain
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
US9610351B2 (en) 2011-10-24 2017-04-04 Mannkind Corporation Methods and compositions for treating pain
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
USD797920S1 (en) 2013-11-22 2017-09-19 Glenmark Pharmaceuticals Limited Inhaler
USD804015S1 (en) 2013-12-23 2017-11-28 Glenmark Pharmaceuticals Limited Inhaler
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
USD795414S1 (en) 2014-06-03 2017-08-22 Glenmark Specialty S.A. Inhaler
USD767114S1 (en) 2015-03-18 2016-09-20 Amneal Pharmaceuticals Company Gmbh Inhalation device
USD769439S1 (en) 2015-03-18 2016-10-18 Amneal Pharmaceuticals Company Gmbh Inhalation device

Similar Documents

Publication Publication Date Title
USD439172S1 (en) Watch casing and bezel
USD461995S1 (en) Tray
USD476889S1 (en) Can end
USD494870S1 (en) Bottle
USD468365S1 (en) Dataplay player
USD474690S1 (en) Bottle
USD493721S1 (en) Flask
USD481125S1 (en) Connector for endoscope
USD524637S1 (en) Anti-tamper fastener
USD475531S1 (en) Toothbrush
USD450843S1 (en) Thrombectomy handpiece
USD473411S1 (en) Wire caddy
USD482945S1 (en) Saw blade
USD485624S1 (en) Candle stand
USD499816S1 (en) Moulding
USD480921S1 (en) Weaning bowl
USD452155S1 (en) Can end
USD489573S1 (en) Tumbler
USD498846S1 (en) Endoscope
USD480304S1 (en) Can end
USD461243S1 (en) Ellipsoidal syringe barrel
USD492766S1 (en) Earplug
USD451420S1 (en) Wrist band
USD472041S1 (en) Portion of a shoe upper
USD481118S1 (en) Earplug